Globus Medical Stock Drops 7% On CEO Transition And Preliminary Q2 Sales Update

(RTTNews) - Globus Medical, Inc. (GMED) fell 6.42 percent to $52.72 on Monday after announcing leadership changes and preliminary second-quarter sales results.

Shares opened at $53.36 and have traded between $52.22 and $53.75 so far, compared to a previous close of $56.34 on the New York Stock Exchange. The stock's 52-week range is $52.22 to $94.93, with a volume of 2.06 million shares against an average of 1.54 million.

Keith Pfeil, currently EVP, COO, and CFO, will become President and CEO on July 18, succeeding Daniel Scavilla, who is resigning to pursue another opportunity. Kyle Kline will step in as SVP and CFO.

The company expects second quarter 2025 sales of approximately $745.3 million, up 18.4 percent year over year, with base business sales of $650.8 million, a 3.3 percent increase excluding contributions from Nevro.